Medical Cannabinoids in Children and Adolescents: A Systematic Review.

The Use of Medical Cannabinoids in Children and Adolescents

The field of medical marijuana is a hot topic, especially with the legalization of medical marijuana in many states. This study delves into the use of cannabinoids, the active compounds in marijuana, as a medical treatment for children and adolescents. The researchers conducted a systematic review of published reports to uncover the evidence base for cannabinoids in this population. They looked at a wide range of medical conditions, including chemotherapy-induced nausea and vomiting, epilepsy, spasticity, neuropathic pain, posttraumatic stress disorder, and Tourette syndrome.

Evidence for Medical Cannabinoids in Children

The study revealed strong evidence for cannabinoids' effectiveness in treating chemotherapy-induced nausea and vomiting. There was also increasing evidence for their benefit in epilepsy. However, for other conditions like spasticity, neuropathic pain, posttraumatic stress disorder, and Tourette syndrome, the evidence was insufficient.

Potential Risks of Medical Cannabinoids

While the results are promising for certain conditions, the researchers highlight the need for further research, especially considering the potential psychiatric and neurocognitive adverse effects identified from studies of recreational cannabis use. It's important to remember that even though medical marijuana is becoming more accessible, we need to understand its long-term effects before widespread use in children and adolescents.

Dr.Camel's Conclusion

Like a camel navigating the vast desert, we need to cautiously explore the potential benefits and risks of medical cannabinoids in children and adolescents. While this study provides valuable insights, further research is crucial to establish clear guidelines for their safe and effective use in this vulnerable population.